Streetbeat News

Stock Prices

INHD

Shares of Inno Holdings Inc (INHD) were halted due to a circuit breaker triggered by a rapid increase in the stock price. This mechanism is designed to prevent excessive volatility and provide a cooling-off period for investors to assess market conditions.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:41 pm

INHD

Inno Holdings shares have resumed trading. There is no additional context provided in the article regarding the reasons for the trading halt or the implications of the resumption.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:40 pm

CTKB

Cytek Biosciences' stock (CTKB) is trading higher following an initiation of coverage by Stephens & Co. with an Overweight rating and a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:38 pm

PACB

Pacific Biosciences of California (PACB) shares have risen following an initiation of coverage by Stephens & Co with an Overweight rating and a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:32 pm

NXTC

Needham analyst Gil Blum has maintained a Buy rating on NextCure (NASDAQ:NXTC) but has reduced the price target from $6 to $4.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:30 pm

DHR

Danaher Inc. (NYSE:DHR) shares increased by 2.04% to $231.49, with a 9.05% rise over the past month but a 1.82% fall over the past year. The stock's P/E ratio of 28.61 is lower than the Life Sciences Tools & Services industry average of 41.12, suggesting it might be undervalued or have weaker growth prospects.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:30 pm

IRWD

Ironwood Pharmaceuticals' stock (IRWD) is trading higher following an Overweight rating initiation and a $20 price target from Wells Fargo.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:21 pm

BLUE

Bluebird Bio's stock is trading higher following the announcement of an outcomes-based agreement with an organization that covers around 100 million lives in the U.S. The company also expects 85 to 105 patient starts across its three commercial products in 2024.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:19 pm

PG

Procter & Gamble Co. (NYSE:PG) stock has been performing well, with a 2.3% rise in December 2023. The article explains how investors can earn $500 monthly by investing in PG stock, requiring the purchase of approximately 1,582 shares, equating to an investment of about $240,963 based on the current dividend yield of 2.47%. It also discusses the impact of stock price changes on dividend yield and the potential for dividend increases if the company's profits rise.

Portfolio Pulse from judithnwadigo@gmail.com

December 14, 2023 | 4:18 pm

APLS

Wells Fargo analyst Derek Archila has downgraded Apellis Pharmaceuticals (NASDAQ:APLS) from Overweight to Equal-Weight and reduced the price target from $67 to $54.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:17 pm